These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29313231)

  • 21. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
    Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
    Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin suppresses sonic hedgehog expression in pancreatic cancer cells.
    Nakamura M; Ogo A; Yamura M; Yamaguchi Y; Nakashima H
    Anticancer Res; 2014 Apr; 34(4):1765-9. PubMed ID: 24692708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
    Mimeault M; Moore E; Moniaux N; Hénichart JP; Depreux P; Lin MF; Batra SK
    Int J Cancer; 2006 Feb; 118(4):1022-31. PubMed ID: 16108016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells.
    Schiapparelli P; Shahi MH; Enguita-Germán M; Johnsen JI; Kogner P; Lázcoz P; Castresana JS
    Cancer Lett; 2011 Nov; 310(2):222-31. PubMed ID: 21803487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hedgehog Signaling Modulates the Release of Gliotransmitters from Cultured Cerebellar Astrocytes.
    Okuda H; Tatsumi K; Morita-Takemura S; Nakahara K; Nochioka K; Shinjo T; Terada Y; Wanaka A
    Neurochem Res; 2016 Feb; 41(1-2):278-89. PubMed ID: 26694649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.
    Shafaee Z; Schmidt H; Du W; Posner M; Weichselbaum R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):765-70. PubMed ID: 16552573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog signaling in the murine melanoma microenvironment.
    Geng L; Cuneo KC; Cooper MK; Wang H; Sekhar K; Fu A; Hallahan DE
    Angiogenesis; 2007; 10(4):259-67. PubMed ID: 17762973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
    Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
    J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases.
    Warzecha J; Dinges D; Kaszap B; Henrich D; Marzi I; Seebach C
    Int J Mol Med; 2012 Mar; 29(3):423-7. PubMed ID: 22138977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
    Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
    Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth.
    Xu L; Wang X; Wan J; Li T; Gong X; Zhang K; Yi L; Xiang Z; Xu M; Cui H
    Mol Cell Biochem; 2012 May; 364(1-2):235-41. PubMed ID: 22350753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
    Gould A; Missailidis S
    Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells.
    Hu WG; Liu T; Xiong JX; Wang CY
    Acta Pharmacol Sin; 2007 Aug; 28(8):1224-30. PubMed ID: 17640486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of Hedgehog-Gli 1 signaling pathway on proliferation and apoptosis of hepatic stellate cells].
    Liu J; Xu XF; Yang WJ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):33-7. PubMed ID: 19203449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition.
    El-Zaatari M; Grabowska AM; McKenzie AJ; Powe DG; Scotting PJ; Watson SA
    Regul Pept; 2008 Feb; 146(1-3):131-9. PubMed ID: 17996964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
    Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
    Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
    Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
    Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sonic hedgehog signaling enhanced the expression of histone demethylase, lysine-specific demethylase 8 in the head and neck squamous cell carcinoma cell line SCC-6].
    Yin XN; Ma YS; Du J; Fan ZP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Feb; 48(2):77-80. PubMed ID: 23714058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
    Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
    Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.